Stahl M - Search Results

1

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, et al. Harstrick A, et al. Among authors: stahl m. J Clin Oncol. 1991 Sep;9(9):1549-55. doi: 10.1200/JCO.1991.9.9.1549. J Clin Oncol. 1991. PMID: 1651992

2

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

Schöber C, Schmoll E, Schmoll HJ, Poliwoda H, Schuppert F, Stahl M, Bokemeyer C, Wilke H, Weiss J. Schöber C, et al. Among authors: stahl m. Eur J Cancer. 1992;28A(10):1664-6. doi: 10.1016/0959-8049(92)90064-9. Eur J Cancer. 1992. PMID: 1382494

3

Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.

Harstrick A, Bokemeyer C, Preusser P, Köhne-Wömpner CH, Meyer HJ, Stahl M, Knipp H, Schmoll HJ, Wilke H. Harstrick A, et al. Among authors: stahl m. Cancer Chemother Pharmacol. 1992;29(4):321-2. doi: 10.1007/BF00685952. Cancer Chemother Pharmacol. 1992. PMID: 1537080 Clinical Trial.

4

Cytokines and cytotoxic agents in renal cell carcinoma: a review.

Stahl M, Wilke HJ, Seeber S, Schmoll HJ. Stahl M, et al. Semin Oncol. 1992 Apr;19(2 Suppl 4):70-9. Semin Oncol. 1992. PMID: 1553577 Review. No abstract available.

5

The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.

Schöber C, Bokemeyer C, Stahl M, Wilke HJ, Schmoll HJ, Poliwoda H. Schöber C, et al. Among authors: stahl m. Semin Oncol. 1992 Apr;19(2 Suppl 3):131-5. Semin Oncol. 1992. PMID: 1557638

6

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Among authors: stahl m. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

7

Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer.

Wilke H, Stahl M, Schmoll HJ, Preusser P, Fink U, Meyer HJ, Achterrath W, Knipp H, Köhne-Wömpner CH, Harstrick A, et al. Wilke H, et al. Among authors: stahl m. Semin Oncol. 1992 Apr;19(2 Suppl 3):215-9. Semin Oncol. 1992. PMID: 1557651 Review.

8

A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.

Stahl M, Wilke H, Schmoll HJ, Schöber C, Diedrich H, Casper J, Freund M, Poliwoda H. Stahl M, et al. Ann Oncol. 1992 Feb;3(2):167-8. doi: 10.1093/oxfordjournals.annonc.a058136. Ann Oncol. 1992. PMID: 1606089 Free article. Clinical Trial.

9

New developments in the treatment of gastric carcinoma.

Wilke H, Preusser P, Fink U, Achterrath W, Mayer HJ, Stahl M, Lenaz L, Meyer J, Siewert JR, Gerlings H, et al. Wilke H, et al. Among authors: stahl m. Cancer Treat Res. 1991;55:363-73. doi: 10.1007/978-1-4615-3882-0_21. Cancer Treat Res. 1991. PMID: 1681867

10

[Modern therapeutic strategies in stomach cancer].

Wilke H, Preusser P, Fink U, Meyer HJ, Schmoll HJ, Stahl M, Seeber S. Wilke H, et al. Among authors: stahl m. Z Gastroenterol Verh. 1991 Mar;26:217-8. Z Gastroenterol Verh. 1991. PMID: 1714153 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,161 results

Search Page

Filters